Dr. Wu, the president of CHO Pharma, spoke about “The Distance between Academe and Industry” at 2022 NBRP (National Biotechnology Research Park) Demo Day


1.Talk Notes

2.Talk Slides

Press Release: Sparking Synergy! CHO Pharma and StemCyte Combine Antibody with Homogenous Glycan and Cell Therapy to Develop New Cancer Therapy.
“With the Key Technology, CHO Pharma Aims to be Global Design House of Glycan New Drug”, Money Weekly, March 24, 2022